PDLIM7 and nasopharyngeal carcinoma: In addition, further testing using proteasome inhibitor MG132 was able to partially inhibit LMP1 mediated RIG-I degradation, for which LMP1 might be responsible for the recruitment of E3 ligases and, therefore, for proteasome-dependent RIG-I degradation in EBV positive NPC cells [101].